Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF JULY 01, 2007 FBO #2043
SOURCES SOUGHT

A -- Identify manufacturers that have Good Manufacturing Practices (cGMP) capability to produce purified drug substance (PDS) at intermediate and commercial scale.

Notice Date
6/29/2007
 
Notice Type
Sources Sought
 
NAICS
541710 — Research and Development in the Physical, Engineering, and Life Sciences
 
Contracting Office
US Army Space and Missile Defense Command, Deputy Commander, ATTN SMDC-CM-AP, P.O. Box 1500, Huntsville, AL 35807-3801
 
ZIP Code
35807-3801
 
Solicitation Number
W9113M-S-0008
 
Response Due
7/15/2007
 
Archive Date
9/13/2007
 
Small Business Set-Aside
N/A
 
Description
This is a sources sought notice. The purpose of this announcement is to identify manufacturers that have current Good Manufacturing Practices (cGMP) capability to produce purified drug substance (PDS) at intermediate and commercial scale. The antig enic component of this vaccine is a single protein produced from a fusion of the Yersinia pestis genes for the F1 capsular protein and the V virulence protein (rF1V). The Department of Defense (DoD), through the Chemical Biological Medical Systems (CBMS) Joint Vaccine Acquisition Program (JVAP) is seeking contractors capable of completing the process definition, technical transfer, and cGMP manufacture of PDS at intermediate and commercial sale. The capabilities are as follows: 1) Confirm the process def inition; 2) Achieve successful technical transfer and cGMP manufacture of purified drug substance (PDS) using an intermediate production scale (100L) process. This includes microbial fermentation and purification of PDS at the 100L scale, technical transf er and validation of product specific assays, PDS testing, and cGMP lot release; 3) Scale-up and optimize a cGMP commercial scale at a minimum of 1000L. Execution of process characterization and process validation studies is required. In addition, the ro uting cGMP commercial manufacture and lot release of rF1V PDS is required to supply product for clinical and nonclinical studies and stockpile of final licensed product. This is not a request for competitive proposals, however, parties interested in respo nding must furnish, in writing , a 1-2 page synopsis of their capabilities and related past performance. Any information received in response to this sources sought notice that is marked proprietary will be handled accordingly. This information may be su bmitted via mail, email, or fax. All responses are to be submitted by not later 15 July 2007 by 3:00PM EST in order to be accepted for review. All paperwork must be sent to U.S. Army Space and Missile Defense Command, ATTN: Lynn Selfridge, 64 Thomas Joh nson Drive, Frederick MD 21702, or Fax 301-619-5069, or email lynn.selfridge@det.amedd.army.mil. This notice should not be construed as a request for proposals or an obligation on the part of the U.S. Government and responses cannot be accepted by the Gov ernment to form a binding contract. Any work effort that may result from this sources sought notice will be conducted through a prime systems contractor and the Government.
 
Place of Performance
Address: US Army Space and Missile Defense Command, Deputy Commander ATTN SMDC-CM-AP, P.O. Box 1500 Huntsville AL
Zip Code: 35807-3801
Country: US
 
Record
SN01331810-W 20070701/070629231520 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.